Whitehouse among senators urging Purdue not to seek profit from new overdose drug

SEN. SHELDON WHITEHOUSE, D-R.I., is one of three senators asking Purdue Pharma to commit in writing to not seek profit from the sale of a new, more effective opioid-overdose drug the company has recently developed. / COURTESY OFFICE OF SHELDON WHITEHOUSE
PROVIDENCE – Sens. Sheldon Whitehouse, D-R.I., Edward J. Markey, D-Mass., and Joe Manchin, D-W.Va., on March 28 sent a letter to Purdue Pharma, manufacturer and marketer of the addictive painkiller OxyContin, urging the company to back up, in writing, its pledge not to seek profit from sales of a new overdose-treatment drug. The senators wrote…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

No posts to display